NeoStrata Problem Dry Skin Cream PHA 20 Review

Name: NeoStrata Problem Dry Skin Cream PHA 20 Review
Item: NeoStrata Problem Dry Skin Cream PHA 20
Rating: 68
Author: DermApproved

Verdicts

How well it fits each concern

Verdict by concern tap a concern for the case

Strong choicefor DrynessPetrolatum is an approved or monograph active for dryness; this cream carries it.Moderate evidenceGentleNo reviews collected yet

The case for it

Petrolatum is a first-line active — approved, monograph-listed or named in current guidelines — for this concern.
It is plausibly present at a working level, though the concentration is not declared.
The formula carries none of the triggers this concern is sensitive to.

What would change this: A declared concentration would move this to a firmer reading of the dose.

Same rule for everyone. “Strong choice” is the verdict on 1,459 of 45,024 concern verdicts across the catalog; rule R3 decided 567 of them. Unchanged since September 5, 2026, engine 5.1.1.

Brand or formulator? Disclose a concentration or correct a fact →

Show the work

Rule: R3 — Undeclared but plausibly dosed (top-third INCI position, or a potent sub-1% active) — the verdict stands, and the sentence says what disclosure would add. A declared figure below range would have been sub-threshold. · the full register
Carrying active: Petrolatum
Standing: first line — a regulator recognises it for this use; its mechanism is established · per § 347.50 Labeling of skin protectant drug products (indications for § 347.10 actives, incl. petrolatum) (U.S. Food and Drug Administration — 21 CFR Part 347 Subpart B, Code of Federal Regulations via GovInfo), opened July 27, 2026
Form: plausible — studied range 1–100%, from the trials on the row; needs leave-on contact; judge it after ~1 weeks
Tolerability: gentle
Row checked: against its sources on July 27, 2026 (evidence table ev-2026.09-r228)

The studies behind the evidence row

International Cosmetic Ingredient Dictionary and Handbook — declared function — Personal Care Products Council
United States Pharmacopeia / National Formulary — excipient monograph — USP-NF
Harry's Cosmeticology / Baran & Maibach Textbook of Cosmetic Dermatology — humectant, emollient and occlusive classification — standard reference text

All dryness products →

Supporting rolefor Keratosis PilarisGlycolic Acid has early evidence for keratosis pilaris, and emollient hydration is the recognised companion to treating it — a reasonable supporting choice, short of a recommendation.Limited evidenceGentleNo reviews collected yet

The case for it

Glycolic Acid has early or mechanistic evidence for this concern, not trial-backed standing.
It is plausibly present at a working level, though the concentration is not declared.
The formula carries none of the triggers this concern is sensitive to.

What would change this: A declared concentration would move this to a firmer reading of the dose.

Same rule for everyone. “Supporting role” is the verdict on 8,197 of 45,024 concern verdicts across the catalog; rule R8a decided 1,489 of them. Unchanged since September 5, 2026, engine 5.1.1.

Brand or formulator? Disclose a concentration or correct a fact →

Show the work

Rule: R8a — A plausible-tier active in a category with a supportive job: the sentence names the active instead of saying nothing targets the concern (the AmLactin / CeraVe SA case for keratosis pilaris, where no guideline and single trials leave the keratolytics at early evidence). · the full register
Carrying active: Glycolic Acid
Standing: plausible — trials support it
Form: plausible
Tolerability: gentle
Row checked: against its sources on July 17, 2026 (evidence table ev-2026.09-r228)

The studies behind the evidence row

Clinical outcomes and 5-year follow-up results of keratosis pilaris treated by a high concentration of glycolic acid — World Journal of Clinical Cases (high-concentration peel cohort; not a vehicle-controlled leave-on RCT) (2021), opened July 17, 2026
Two is better than one: The combined effects of glycolic acid and salicylic acid on acne-related disorders — Journal of Cosmetic Dermatology (combination serum, questionnaire endpoint — does not isolate glycolic) (2020), opened July 17, 2026

All keratosis pilaris products →

Supporting rolefor PsoriasisLactic Acid has early evidence for psoriasis, and emollient therapy is the recognised companion to treating it — a reasonable supporting choice, short of a recommendation.Limited evidenceGentleNo reviews collected yet

The case for it

Lactic Acid has early or mechanistic evidence for this concern, not trial-backed standing.
It is plausibly present at a working level, though the concentration is not declared.
The formula carries none of the triggers this concern is sensitive to.

What would change this: A declared concentration would move this to a firmer reading of the dose.

Same rule for everyone. “Supporting role” is the verdict on 8,197 of 45,024 concern verdicts across the catalog; rule R8a decided 1,489 of them. Unchanged since September 5, 2026, engine 5.1.1.

Brand or formulator? Disclose a concentration or correct a fact →

Show the work

Rule: R8a — A plausible-tier active in a category with a supportive job: the sentence names the active instead of saying nothing targets the concern (the AmLactin / CeraVe SA case for keratosis pilaris, where no guideline and single trials leave the keratolytics at early evidence). · the full register
Carrying active: Lactic Acid
Standing: plausible — trials support it
Form: plausible — studied range 12%, from the OTC monograph or label; needs leave-on contact; judge it after ~4 weeks
Tolerability: gentle
Row checked: against its sources on July 17, 2026 (evidence table ev-2026.09-r228)

The studies behind the evidence row

Salicylic Acid 6% in an ammonium lactate emollient foam vehicle in the treatment of mild-to-moderate scalp psoriasis — Journal of Drugs in Dermatology (2011), opened July 17, 2026

All psoriasis products →

Good choicefor Rough TextureGlycolic Acid is a reference standard by mechanism for rough texture; this cream carries it high in the ingredient list.Moderate evidenceGentleNo reviews collected yet

The case for it

Glycolic Acid has trial-supported standing for this concern.
It is present at an effective concentration, declared or high in the ingredient list.
The formula carries none of the triggers this concern is sensitive to.

Same rule for everyone. “Good choice” is the verdict on 9,564 of 45,024 concern verdicts across the catalog; rule R5 decided 9,072 of them. Unchanged since September 5, 2026, engine 5.1.1.

Brand or formulator? Disclose a concentration or correct a fact →

Show the work

Rule: R5 — Trial-supported or guideline-supported active, adequately or plausibly dosed. · the full register
Carrying active: Glycolic Acid
Standing: supported — its mechanism is established
Form: adequate — studied range 4–10%, from the trials on the row; needs leave-on contact; judge it after ~8 weeks
Tolerability: gentle
Row checked: against its sources on July 17, 2026 (evidence table ev-2026.09-r228)

The studies behind the evidence row

International Cosmetic Ingredient Dictionary and Handbook — declared function — Personal Care Products Council
Harry's Cosmeticology / Baran & Maibach Textbook of Cosmetic Dermatology — humectant, emollient and occlusive classification — standard reference text

All rough texture products →

As a body productNot judged: what a body product is for — real substance, not just slip, realistic to use daily — cannot yet be measured from the ingredient list (only fragrance load can).

A verdict is DermApproved’s assessment of how well a product’s ingredients fit a concern — never a claim about what the product treats. Evidence dots and collected reviews sit beside it and are never blended in. Rules 0.5.1 · evidence table ev-2026.09-r228 · how we decide

Assessment

Pros & Cons

Pros

✓ Four-acid blend at 20% concentration provides multi-depth exfoliation unmatched by single-acid body creams
✓ PHA and bionic acid components add moisturizing and antioxidant properties that buffer irritation from the high acid load
✓ Dramatically effective for calloused heels, with clinical data showing significant improvement in three weeks
✓ Occlusive petrolatum and beeswax base locks moisture into freshly exfoliated skin
✓ Fragrance-free formula suitable for those who react to scented body treatments
✓ Effective for keratosis pilaris with consistent daily use over 3-4 weeks
✓ From the brand that invented AHA and PHA technology with decades of clinical research

Cons

✗ 3.4 oz tube is small for a body treatment at $46, limiting coverage area per tube
✗ Initial stinging sensation on dry or cracked skin may deter some users during the first week
✗ Contains parabens (methylparaben, propylparaben) which some users prefer to avoid
✗ Colorants (Red 33, Yellow 5) add no functional benefit to a clinical treatment product
✗ Not suitable for facial use — the 20% acid concentration is far too intense for the face

Review

Full Review

Some products are evolutionary. Others are archaeological. NeoStrata's Problem Dry Skin Cream is the latter — it's a direct descendant of the research that launched an entire skincare category. When Dr. Van Scott and Dr. Ruey Yu published their findings on alpha hydroxy acids and their ability to normalize keratinization in hyperkeratotic skin conditions, they were describing exactly the mechanism this cream delivers four decades later.

The formula centers on a 20% blend of four acids, each chosen for a specific molecular job. Glycolic acid, the smallest AHA, drives deepest into thickened skin to break the bonds between stubborn dead cells. Lactic acid follows with mid-range penetration and an added benefit: it's a natural humectant, pulling moisture into the skin even as it exfoliates. Mandelic acid, with its larger molecular structure, provides gentler surface exfoliation. And gluconolactone — NeoStrata's signature PHA — exfoliates while functioning as a humectant and antioxidant, essentially moisturizing and protecting the skin it's resurfacing.

The fourth acid, maltobionic acid, is worth singling out. This is a bionic acid, a next-generation evolution of PHA technology that NeoStrata developed. It provides powerful antioxidant properties and moisture retention at the skin surface, creating a hydrating layer that counterbalances the stripping potential of four simultaneous acids at 20% concentration. It's the formulation detail that separates this from crude high-concentration glycolic acid treatments.

The vehicle is equally deliberate. Petrolatum and beeswax create an occlusive barrier that locks moisture into freshly exfoliated skin — critical when you're removing layers of dead cells and need the newly exposed tissue to stay hydrated. Dimethicone smooths the texture, propylene glycol enhances ingredient penetration, and tocopheryl acetate provides vitamin E's antioxidant protection. This isn't a lightweight lotion with acids sprinkled in. It's a heavy-duty treatment cream engineered for skin that normal moisturizers have given up on.

In practice, the cream applies with satisfying richness. It's thick enough to feel therapeutic but not so heavy that it sits on the surface refusing to absorb. On heels and elbows, it sinks in within a few minutes, leaving a smooth, non-greasy feel. The first application on very dry or cracked skin will likely produce a tingling or mild stinging sensation — this is the acid concentration making contact with compromised skin. The sensation is temporary, typically subsiding within two to three minutes, and diminishes noticeably with each subsequent application as the skin surface normalizes.

The first week comes with its own field notes. Accelerated flaking in the opening days is the mechanism made visible — loosened layers letting go — not a reaction to abort over. A forearm test before committing to larger areas is sensible given the concentration. And the routine stays minimalist: nothing else is needed over treated areas, no follow-up moisturizer, and emphatically no stacking — other acid body treatments or retinoid body lotions on the same patches of skin turn a controlled resurfacing into an uncontrolled one.

The results build with impressive consistency. Within the first week, rough patches begin to soften. By week two, you can feel the difference in texture under your fingertips. At the three-week mark — which clinical testing confirms — calloused heels and rough body skin show significant visual improvement. Users who've committed to months of use describe heels that stay smooth year-round, KP bumps that flatten to near-invisibility, and elbows that lose their perpetual roughness.

Three eligibility notes round out the picture. First, sun: AHAs photosensitize, so shins, arms, or any treated area that sees daylight needs sunscreen — a rule that matters most in sandal season, exactly when heel-repair campaigns peak. Second, the condition map is more precise than 'dry skin': thickened, keratotic problems — calluses, KP, psoriatic scale — are the target, while eczema and rosacea are avoid-outright, because broken, inflamed skin and a 20% acid load are a miserable combination. It's flagged pregnancy-safe, and — a rare perk — HSA/FSA eligible with a letter of medical necessity, a nod to how close this sits to actual therapy.

Honesty requires acknowledging the limitations. This is a body-only product, and applying it to the face would be a painful mistake — the 20% acid concentration on thinner facial skin would cause significant irritation. The tube is 3.4 oz, which is small for a body treatment priced at $46; if you're treating large areas like both arms for KP, you'll run through it in about six weeks. And the formula does contain parabens (methyl and propyl), which some consumers prefer to avoid — though it's worth noting that at a 20% acid concentration, the formula's preservation challenges are genuine, and parabens remain among the most well-studied and effective preservatives available.

The colorants (Red 33 and Yellow 5) give the cream a slightly pink-tinged hue but serve no functional purpose, which feels unnecessary in a clinical product.

The review base is small but emphatic: three hundred fifty ratings averaging 4.7, among the highest marks in the body-treatment category. Long-term users write about heels that stay smooth through the year and KP that finally flattened; the complaints are the initiation sting, the parabens, the small tube, and a recurring cautionary tale — people who ignored the body-only instruction and tried it on their face, once.

For its intended purpose — treating severely dry, rough, calloused, or keratotic body skin — this cream is remarkably effective. It exists at the intersection of dermatological treatment and consumer skincare, and that's exactly where NeoStrata has always been most comfortable. The multi-acid approach is smarter than the single-acid alternatives because it exfoliates at different depths simultaneously, and the emollient vehicle ensures the exfoliation leads to renewal rather than further drying.

This is not a glamorous product. It won't trend on social media or sit prettily on a shelfie. But for anyone who's fought with cracked heels, persistent keratosis pilaris, or skin so dry and rough that regular moisturizers barely register — this is the product that actually works. It's NeoStrata doing what NeoStrata does best: turning serious acid science into real results for real skin problems.

Formula

Key Ingredients

The hero actives that drive this product's performance.

Ingredient	Function	Evidence
Glycolic Acid	The smallest AHA leads this cream's 20% acid blend, penetrating deeply into thickened, calloused skin to dissolve the intercellular bonds holding dead cells together. In this heavy-duty body formula, glycolic acid does the aggressive heavy lifting while the PHA and larger AHAs provide supporting exfoliation at different depths.	Established mechanism for Rough Texture · established mechanism
Gluconolactone (PHA)	NeoStrata's signature polyhydroxy acid provides exfoliation without the sting of pure glycolic acid. In this high-concentration formula, gluconolactone acts as the gentler partner — exfoliating while simultaneously humecting and chelating metal ions to reduce free radical irritation from the aggressive AHA blend.	Not yet assessed
Maltobionic Acid	A next-generation bionic acid that provides antioxidant protection and moisture retention in this intensive formula. Its large molecular structure means it works at the skin surface, creating a hydrating film that offsets the drying potential of the glycolic and lactic acids penetrating below.	Not yet assessed
Lactic Acid	Provides mid-range AHA exfoliation in this blend while contributing its natural moisturizing properties — lactic acid is both an exfoliant and a humectant, helping to hydrate the very skin it's resurfacing. Works in tandem with glycolic acid to address different layers of dry, thickened skin.	Established mechanism for Rough Texture · established mechanism
Petrolatum	Creates an occlusive seal over the treated skin, locking in the moisture provided by the PHA humectants and preventing transepidermal water loss from the freshly exfoliated surface. Essential in this formula to prevent the 20% acid concentration from leaving skin dehydrated after exfoliation.	Regulator-approved for Dryness · established mechanism
Tocopheryl Acetate (Vitamin E)	Provides antioxidant protection to the newly exposed skin cells revealed by the intense acid exfoliation, while also supporting the skin's moisture barrier repair process. Works alongside the petrolatum and beeswax to condition and protect the treated areas.	Not yet assessed

Full INCI List

Ammonium Hydroxide, Aqua/Water/Eau, Arginine, Cera Alba, Cetyl Alcohol, Dimethicone, Disodium EDTA, Gluconolactone, Glycolic Acid, Lactic Acid, Magnesium Aluminum Silicate, Maltobionic Acid, Mandelic Acid, Methylparaben, Paraffinium Liquidum, PEG-40 Stearate, Petrolatum, Propylene Glycol, Propylparaben, Red 33 (CI 17200), Sodium Bisulfite, Sorbitan Stearate, Stearyl Alcohol, Tocopheryl Acetate, Xanthan Gum, Yellow 5 (CI 19140)

Safety & Formulation Facts

✓ Pregnancy Safe ✓ Fragrance Free✓ Alcohol Free✗ Oil Free✗ Silicone Free✗ Paraben Free✓ Sulfate Free✗ Cruelty Free✗ Vegan✗ Fungal Acne Safe

Comedogenic Ingredients

PetrolatumCetyl Alcohol

Potential Irritants

Glycolic Acid at high concentrationPropylene Glycol

Compatibility

Skin Match

Best For

dry

Works For

normal

Not Ideal For

oily sensitive

Routine Step

treatment

Time of Day

AM & PM

Layering Tips

Apply directly to problem areas on the body — heels, elbows, knees, shins. This is a body treatment, not intended for the face. No additional moisturizer is needed over treated areas. Always use sunscreen on treated areas exposed to sun, as AHAs increase photosensitivity.

Results Timeline

Noticeable softening of rough patches within the first few applications. Significant improvement in calloused skin, scaling, and roughness after 3 weeks of once-daily use. Ongoing maintenance keeps problem areas smooth with continued use.

Pairs Well With

Broad-spectrum sunscreen on exposed treated areasGentle body wash

Planning a combo? Check it against what you already use

Conflicts With

Other high-concentration AHA body treatmentsRetinoid body lotions on the same areas

See where it fits — layering order & night-splitting

Sample AM Routine

Gentle body wash
NeoStrata Problem Dry Skin Cream on rough areas
Sunscreen on exposed treated skin

Sample PM Routine

Gentle body wash
NeoStrata Problem Dry Skin Cream on rough areas

Evidence

Science & Expert Perspective

The Science

The scientific foundation of this cream draws directly from NeoStrata's founding research. Glycolic acid's mechanism of action in hyperkeratotic skin is well-characterized: it disrupts ionic bonding between corneocytes at the lowest levels of the stratum corneum, accelerating desquamation and promoting normalization of the keratinization cycle. At concentrations of 10-20%, glycolic acid has been shown in numerous published studies to significantly reduce visible scaling, roughness, and corneocyte cohesion.

The inclusion of lactic acid adds a complementary mechanism: beyond its AHA exfoliating action, lactic acid stimulates ceramide production in the epidermis, as demonstrated in published research, effectively helping the skin rebuild its barrier even as the formula exfoliates. This dual action is particularly valuable for chronically dry skin where barrier dysfunction contributes to the problem.

Gluconolactone (PHA) contributes NeoStrata's most distinctive innovation. Work appearing in the Journal of the European Academy of Dermatology and Venereology demonstrated that PHAs provide exfoliating and anti-aging effects comparable to AHAs while producing significantly less sensory irritation. The mechanism involves gluconolactone's polyhydroxy structure, which chelates transition metal ions (reducing Fenton reaction-mediated free radical generation) while also acting as a humectant due to its multiple hydroxyl groups.

Maltobionic acid, a bionic acid co-developed by NeoStrata, extends this principle further: its disaccharide structure provides even stronger antioxidant and humectant properties than gluconolactone alone, while still delivering meaningful exfoliation. The combination of all four acid types at 20% total concentration represents a sophisticated tiered-penetration strategy that addresses hyperkeratotic skin from the surface through to the deeper stratum corneum.

References

Glucosamine: an ingredient with skin and other benefits. — Journal of Cosmetic Dermatology (2007)

Dermatologist Perspective

Practicing dermatologists frequently recommend high-concentration AHA body creams for hyperkeratotic conditions including keratosis pilaris, ichthyosis, and psoriasis-associated scaling. NeoStrata's Problem Dry Skin Cream is particularly well-regarded in clinical practice because the multi-acid approach with PHA buffering reduces the irritation typically associated with 20% glycolic acid alone. Dermatologists note that the amphoteric formulation design — where the acids are partially neutralized — maintains efficacy while improving tolerability. This product is commonly recommended as a maintenance treatment alongside prescription therapies for chronic dry skin conditions, and its HSA/FSA eligibility reflects its recognition as a medical-grade skin treatment.

Guidance

Usage & Recommendations

How to Use

Apply a thin layer to rough, calloused body areas twice daily — morning and evening. Focus on heels, elbows, knees, shins, and any areas with keratosis pilaris or persistent roughness. For sensitive areas, start with once daily or every other day and increase frequency as tolerated. Test on the inner forearm first if you have reactive skin. Do not apply to the face, open wounds, or actively inflamed skin. Use sunscreen on treated areas exposed to the sun, as AHAs increase photosensitivity.

Value Assessment

At $46 for 3.4 oz, this is not inexpensive for a body product, but it occupies a unique position between prescription treatments and over-the-counter moisturizers. The four-acid blend at 20% concentration delivers clinical-grade results that drugstore AHA lotions at 10-12% simply can't match. For targeted use on problem areas (heels, elbows, KP patches), the tube lasts 6-8 weeks, making the monthly cost approximately $25-30. NeoStrata offers a 15% subscribe-and-save discount at $39.10. For those with chronic dry skin conditions that have resisted conventional moisturizers, the per-application effectiveness arguably makes this more cost-effective than going through multiple bottles of weaker products that don't solve the problem.

Who Should Buy

Anyone battling severely dry, rough, or calloused body skin that hasn't responded to regular moisturizers. This cream is particularly effective for keratosis pilaris, chronically rough heels, scaly elbows and knees, and the scaling associated with psoriasis. Ideal for those who want clinical-strength acid exfoliation in a convenient at-home treatment.

Who Should Skip

Those with sensitive body skin or active eczema should avoid this cream — the 20% acid concentration can cause significant irritation on compromised skin. Anyone expecting a facial product should look elsewhere. If you have mild dryness that responds well to regular moisturizers, this is more intensity than you need — NeoStrata's lower-concentration PHA products would be a better starting point.

Details

Product Details

Texture

Rich, emollient cream with a slightly thick consistency that spreads and absorbs without heavy greasiness

Scent

Fragrance-free with a faint clinical/acidic note typical of high-concentration AHA products

Packaging

Squeeze tube in NeoStrata's Resurface line packaging with clinical branding

Finish

satinnon-greasy

What to Expect on First Use

Expect a tingling or mild stinging sensation on first application, especially on very rough or cracked areas — this subsides within minutes as the skin acclimates. Test on your forearm first. Within the first few days, you may notice accelerated flaking as the acid exfoliation loosens dead skin layers. This is normal and signals the cream is working. Roughness begins to resolve noticeably by week two.

How Long It Lasts

6-8 weeks with twice-a-day use on targeted body areas

Period After Opening

12 months

Opened yours? Track the toss-by date

Best Season

All Year

Certifications

Dermatologist testedAllergy tested

Background

The Story Behind This Product

This cream is one of NeoStrata's longest-running products and perhaps the purest expression of the brand's founding mission. When Dr. Van Scott and Dr. Yu discovered the cosmetic and therapeutic potential of alpha hydroxy acids, treating severely dry, scaly, and calloused skin was among the first clinical applications they pursued. This product essentially packages their original research breakthrough into a consumer-accessible format — it's the closest you can get to the treatment that started it all.

About NeoStrata Legacy Brand (20+ years)

NeoStrata was founded in 1988 by dermatologist Dr. Van Scott and dermatopharmacologist Dr. Ruey Yu, who invented alpha and polyhydroxy acid technology. The brand holds over 110 patents and has published nearly 250 clinical studies and journal papers.

Brand founded: 1988 · Product launched: 2005

Myth vs. Reality

Common Myths

Myth

High-concentration AHA products are always extremely irritating and dangerous.

Reality

This formula's amphoteric (pH-buffered) design and the inclusion of gluconolactone and maltobionic acid significantly reduce the irritation you'd expect from a 20% acid concentration. The PHA and bionic acid components provide exfoliation with built-in moisturization, and the emollient base further buffers the acids. Most users on thick body skin report only mild tingling.

Myth

You can use this cream on your face for intense exfoliation.

Reality

This product is formulated specifically for tough body skin — heels, elbows, knees, and other calloused areas. The 20% acid concentration, combined with the heavy emollient base and colorants, makes it unsuitable and potentially very irritating for facial skin, which is much thinner and more sensitive.

FAQ

Frequently Asked Questions

Can I use NeoStrata Problem Dry Skin Cream on my face?

No — this product is formulated exclusively for body use on rough, calloused areas like heels, elbows, and knees. The 20% acid concentration is too intense for facial skin, and the emollient base with beeswax and petrolatum is too heavy for the face. NeoStrata offers separate facial products with appropriate acid concentrations for the face.

Does NeoStrata Problem Dry Skin Cream help with keratosis pilaris?

Yes — the combination of glycolic acid, lactic acid, and gluconolactone in this cream is effective for the rough, bumpy texture of keratosis pilaris. The multi-acid blend exfoliates the keratin plugs that cause KP bumps, while the emollient base moisturizes the surrounding skin. Many users report significant improvement in arm and leg KP within 3-4 weeks of daily use.

How long does it take for NeoStrata Problem Dry Skin Cream to work?

Most users notice softening of rough patches within the first few applications. Significant visible improvement in calloused skin, scaling, and roughness typically occurs after 3 weeks of once-daily use. For severely calloused heels or stubborn KP, full results may take 6-8 weeks of consistent application.

Does NeoStrata Problem Dry Skin Cream sting?

A mild tingling or stinging sensation is normal during the first few applications, especially on very dry or cracked skin. This is the 20% acid blend working and typically subsides within minutes. The sensation decreases as skin acclimates over the first week. If stinging is severe, reduce to once daily or every other day until your skin adjusts.

Is NeoStrata Problem Dry Skin Cream good for psoriasis?

This cream can help manage the scaling and roughness associated with psoriasis, though it is not a psoriasis treatment. The AHA/PHA blend gently removes accumulated scales and improves skin texture, and the emollient base helps with dryness. However, it should not be applied to actively inflamed or cracked psoriasis plaques. Consult a dermatologist before use if you have active psoriasis.

Reviews

What Reviewers Tend to Say

Recurring themes our editors read across retailer reviews of this product — summaries in our words, not quotations, and not a substitute for your own patch test.

Common Praise

Dramatically smooths rough heels and calloused skin within weeks

Effective for keratosis pilaris bumps on arms and legs

Non-greasy texture absorbs well for such a heavy-duty treatment

Long-term users report consistently smooth feet year-round

Common Complaints

Can sting on sensitive or cracked skin during initial applications

Contains parabens which some users prefer to avoid

3.4 oz tube is small for a body treatment at $46

Not suitable for facial use despite some users attempting it

Notable Endorsements

Dermatologist-developed and recommendedHSA/FSA eligible with letter of medical necessity